BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 35678784)

  • 1. Cost-effectiveness of Debrichem in managing hard-to-heal venous leg ulcers in the UK.
    Guest JF; Deanesi V; Segalla A
    J Wound Care; 2022 Jun; 31(6):480-491. PubMed ID: 35678784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of using intermittent pneumatic compression to manage hard-to-heal venous leg ulcers in the UK.
    Guest JF; Staines K; Murphy N
    J Wound Care; 2021 Jul; 30(7):544-552. PubMed ID: 34256598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of ChloraSolv in treating hard-to-heal venous leg ulcers.
    Guest JF; Apelqvist J
    J Wound Care; 2024 Jan; 33(1):4-13. PubMed ID: 38197275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of using a collagen-containing dressing plus compression therapy in non-healing venous leg ulcers.
    Guest JF; Rana K; Singh H; Vowden P
    J Wound Care; 2018 Feb; 27(2):68-78. PubMed ID: 29424641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modelling the cost-effectiveness of electric stimulation therapy in non-healing venous leg ulcers.
    Taylor RR; Sladkevicius E; Guest JF
    J Wound Care; 2011 Oct; 20(10):464, 466, 468-72. PubMed ID: 22067884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relative cost-effectiveness of three compression bandages in treating newly diagnosed venous leg ulcers in the UK.
    Guest JF; Fuller GW
    J Wound Care; 2023 Mar; 32(3):146-158. PubMed ID: 36930185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcomes and cost-effectiveness of an externally applied electroceutical device in managing venous leg ulcers in clinical practice in the UK.
    Guest JF; Ayoub N; Greaves T
    J Wound Care; 2015 Dec; 24(12):572, 574-80. PubMed ID: 26654737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of two reduced pressure compression systems in treating newly diagnosed venous leg ulcers.
    Guest JF; Fuller GW
    J Wound Care; 2023 Jun; 32(6):348-358. PubMed ID: 37300861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential cost-effectiveness of using a collagen-containing dressing in managing diabetic foot ulcers in the UK.
    Guest JF; Singh H; Vowden P
    J Wound Care; 2018 Mar; 27(3):136-144. PubMed ID: 29509110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and cost-effectiveness of absorbent dressings in the treatment of highly exuding VLUs.
    Panca M; Cutting K; Guest JF
    J Wound Care; 2013 Mar; 22(3):109-10, 112-8. PubMed ID: 23665729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimating the Clinical Outcomes and Cost Differences Between Standard Care With and Without Cadexomer Iodine in the Management of Chronic Venous Leg Ulcers Using a Markov Model.
    Nherera LM; Woodmansey E; Trueman P; Gibbons GW
    Ostomy Wound Manage; 2016 Jun; 62(6):26-40. PubMed ID: 27356144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Venous leg ulcer management in clinical practice in the UK: costs and outcomes.
    Guest JF; Fuller GW; Vowden P
    Int Wound J; 2018 Feb; 15(1):29-37. PubMed ID: 29243398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A cost-effectiveness analysis of a hydration response technology dressing in the treatment of venous leg ulcers in the UK.
    Walzer S; Dröschel D; Vollmer L; Atkin L; Ousey K
    J Wound Care; 2018 Mar; 27(3):166-172. PubMed ID: 29509113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relative cost-effectiveness of a skin protectant in managing venous leg ulcers in the UK.
    Guest JF; Taylor RR; Vowden K; Vowden P
    J Wound Care; 2012 Aug; 21(8):389-94, 396-8. PubMed ID: 22885312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcomes and cost-effectiveness of three different compression systems in newly-diagnosed venous leg ulcers in the UK.
    Guest JF; Fuller GW; Vowden P
    J Wound Care; 2017 May; 26(5):244-254. PubMed ID: 28475441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skin Substitutes for Adults With Diabetic Foot Ulcers and Venous Leg Ulcers: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2021; 21(7):1-165. PubMed ID: 34211616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modelling the relative cost-effectiveness of amelogenin in non-healing venous leg ulcers.
    Guest JF; Nagy E; Sladkevicius E; Vowden P; Price P
    J Wound Care; 2009 May; 18(5):216, 218-24. PubMed ID: 19440174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early versus deferred endovenous ablation of superficial venous reflux in patients with venous ulceration: the EVRA RCT.
    Gohel MS; Heatley F; Liu X; Bradbury A; Bulbulia R; Cullum N; Epstein DM; Nyamekye I; Poskitt KR; Renton S; Warwick J; Davies AH
    Health Technol Assess; 2019 May; 23(24):1-96. PubMed ID: 31140402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of an electroceutical device in treating non-healing venous leg ulcers: results of an RCT.
    Guest JF; Singh H; Rana K; Vowden P
    J Wound Care; 2018 Apr; 27(4):230-243. PubMed ID: 29637824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical outcomes and cost-effectiveness of three alternative compression systems used in the management of venous leg ulcers.
    Guest JF; Gerrish A; Ayoub N; Vowden K; Vowden P
    J Wound Care; 2015 Jul; 24(7):300, 302-5, 307-8, passim. PubMed ID: 26198552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.